CCN2 and systemic sclerosis: Recently, the GG genotype of the CTGF −945 G/C promoter polymorphism was shown to be 2.2 fold higher in patients with systemic sclerosis, compared to control subjects, and was associated with increased incidence of lung fibrosis [22].